Figure 3From: Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study Evolution of anti-HBs antibody geometric mean concentrations (GMCs) during the five years follow-up period (Long-term ATP cohort for immunogenicity) and during the challenge phase (ATP cohort for immunogenicity).Back to article page